Status:
TERMINATED
Her 2 Testing in Indian Patients With Gastric Cancer
Lead Sponsor:
Tata Memorial Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-90 years
Brief Summary
Gastric cancer remains a major health issue and a leading cause of cancer death worldwide, although the prevalence and mortality of the disease have gradually decreased. The investigators have very fe...
Detailed Description
1. Study Objective/ Aims Aim: - Rate of Her 2 positivity in 100 consecutive gastric cancer patients Primary Objective Test for Her 2 in 100 consecutive gastric cancer patients Immuno-histochemistr...
Eligibility Criteria
Inclusion
- 100 consecutive patients with gastric cancer who have a pathology specimen at TMH
Exclusion
- If histopathology blocks were not available
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01814345
Start Date
June 1 2013
End Date
February 1 2017
Last Update
April 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400012